LGALS3 and kidney disorder: In addition to suPAR, galectin-3, a key regulator of fibrosis and inflammation, is strongly associated with cardiac remodeling, hepatic fibrosis, and kidney disease progression, with elevated levels linked to higher mortality in heart failure (HF) and liver fibrosis (8).